Standout Papers

Inherited Mutations in Women With Ovarian Carcinoma 2015 2026 2018 2022 490
  1. Inherited Mutations in Women With Ovarian Carcinoma (2015)
    Barbara M. Norquist, Maria I. Harrell et al. JAMA Oncology
  2. Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial (2017)
    Robert L. Coleman, Mark F. Brady et al. The Lancet Oncology
  3. Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer (2016)
    John K. Chan, Mark F. Brady et al. New England Journal of Medicine

Immediate Impact

12 by Nobel laureates 8 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Macrophages at the interface of the co-evolving cancer ecosystem
2023 Standout
2 intermediate papers

Works of Susan A. Davidson being referenced

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
2017 Standout
Age-Specific Trends From 2000–2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People
2016

Author Peers

Author Last Decade Papers Cites
Susan A. Davidson 1094 407 435 835 606 57 2.4k
Christine Walsh 964 270 655 851 823 91 2.5k
Adam N. Rosenthal 970 405 490 494 588 69 2.3k
Lucy Gilbert 1333 232 678 1030 557 140 3.2k
Matthew Burnell 753 444 285 1081 628 66 3.2k
Ilana Cass 1499 439 828 610 455 66 2.4k
Carolyn Y. Muller 841 579 462 948 1178 101 3.3k
Bruce G. Ward 784 268 291 708 697 57 2.2k
Dianne Miller 1896 523 1157 857 720 74 3.6k
Joseph Menczer 1571 526 840 605 430 166 2.9k
Lee-may Chen 1487 527 894 1237 449 109 3.3k

All Works

Loading papers...

Rankless by CCL
2026